Richard Eno, CFA, is a senior partner at the global management consulting firm, Roland Berger, where he focuses on strategic and operational issues in the energy, chemicals and materials industries. Mr. Eno has deep expertise in strategy development and the application of emerging technology across each of these industries. He has over 30 years of industry experience in a range of senior leadership positions including as a public company CEO.
From 2008 to 2014, Mr. Eno served as President and CEO of Metabolix, an Industrial Biotechnology company commercializing a family of bio-based biodegradable polymers and renewable chemicals. He led the transition of the company from research stage into commercial operations developing over 100 customers around the world. Metabolix products offer a range of sustainable solutions to the performance materials industry.
Prior to Metabolix, Mr. Eno led the global oil and gas consulting practice at CRA International as well as the global Chemicals and Energy Practice at Arthur D. Little. In addition to leading and growing these businesses, Mr Eno advised clients around the world on critical business strategy, operational, organizational and technology issues. His clients included several of the largest companies in the world.
He has served on the Metabolix Board and as Vice Chairman of the Industrial and Environmental Governing Board for the Biotechnology Industry Association.
Mr. Eno has a Chemical Engineering degree from Cornell University (1982), a Masters in Business Administration from the University of Houston (1989). He is a Chartered Financial Analyst and a member of the Boston Security Analysts Society. He is an avid skier, hiker, cyclist and sailor; he and his family immerse themselves in the outdoors year round.